SG10201406839VA - Benzazepine compound - Google Patents
Benzazepine compoundInfo
- Publication number
- SG10201406839VA SG10201406839VA SG10201406839VA SG10201406839VA SG10201406839VA SG 10201406839V A SG10201406839V A SG 10201406839VA SG 10201406839V A SG10201406839V A SG 10201406839VA SG 10201406839V A SG10201406839V A SG 10201406839VA SG 10201406839V A SG10201406839V A SG 10201406839VA
- Authority
- SG
- Singapore
- Prior art keywords
- benzazepine compound
- group
- salt
- present
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Emergency Medicine (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Studio Devices (AREA)
Abstract
-31- BENZAZEPINE COMPOUND Abstract An object of the present invention is to provide a novel benzazepine compound or a salt thereof, which has excellent vasopressin antagonistic activity. The benzazepine compound or a salt thereof of the present invention is represented by Formula (1): wherein R , 1 R 2 and R 5 may be the same or different and each represents H or D; and R 3 and R 4 each represents a Ci_6 alkyl group, a Ci-6 deuteroalkyl group, or a Ci-6 perdeuteroalkyl group. (no suitable figure)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009245434 | 2009-10-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201406839VA true SG10201406839VA (en) | 2014-12-30 |
Family
ID=43921941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201406839VA SG10201406839VA (en) | 2009-10-26 | 2010-10-25 | Benzazepine compound |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8940727B2 (en) |
| EP (1) | EP2495236A4 (en) |
| JP (1) | JP5717645B2 (en) |
| KR (1) | KR20120092139A (en) |
| CN (3) | CN104829531A (en) |
| AU (1) | AU2010312651A1 (en) |
| BR (1) | BR112012009784A2 (en) |
| CA (1) | CA2778756A1 (en) |
| CO (1) | CO6481003A2 (en) |
| EA (1) | EA022253B1 (en) |
| IL (1) | IL219132A0 (en) |
| IN (1) | IN2012DN03343A (en) |
| MX (1) | MX2012004843A (en) |
| SG (1) | SG10201406839VA (en) |
| WO (1) | WO2011052519A1 (en) |
| ZA (1) | ZA201202640B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3711B1 (en) | 2015-07-13 | 2021-01-31 | H Lundbeck As | Antibodies specific for hyperphosphorylated tau and methods of use thereof |
| WO2019003433A1 (en) * | 2017-06-30 | 2019-01-03 | 大塚製薬株式会社 | Benzazepine derivative |
| TW201938171A (en) | 2017-12-15 | 2019-10-01 | 匈牙利商羅特格登公司 | Tricyclic compounds as vasopressin V1a receptor antagonists |
| HU231206B1 (en) | 2017-12-15 | 2021-10-28 | Richter Gedeon Nyrt. | Triazolobenzazepines |
| JP6868089B2 (en) * | 2018-12-28 | 2021-05-12 | 大塚製薬株式会社 | Medicine |
| CN112851583B (en) * | 2021-01-19 | 2023-09-08 | 徐州医科大学 | Novel benzazepine compounds, compositions and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2905909B2 (en) * | 1991-04-19 | 1999-06-14 | 大塚製薬株式会社 | Vasopressin antagonist |
| US5753677A (en) | 1989-10-20 | 1998-05-19 | Otsuka Pharmaceutical Co., Ltd. | Benzoheterocyclic compounds |
| KR0167349B1 (en) | 1989-10-20 | 1999-02-18 | 오스카 아끼히꼬 | Benzoheterocyclic composition |
| US5258510A (en) * | 1989-10-20 | 1993-11-02 | Otsuka Pharma Co Ltd | Benzoheterocyclic compounds |
| ATE239726T1 (en) | 1993-07-21 | 2003-05-15 | Yamanouchi Pharma Co Ltd | FUSED BENZAZEPINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME |
| EP1910322B1 (en) * | 2005-07-29 | 2012-09-05 | Concert Pharmaceuticals Inc. | Novel deuterated benzo [d][1,3]-dioxol derivatives as serotonin reuptake inhibitors |
| JP5528105B2 (en) * | 2006-06-05 | 2014-06-25 | オースペックス・ファーマシューティカルズ・インコーポレイテッド | Preparation and utilization of substituted imidazopyridine compounds with hypnotic effect |
| AU2007310949A1 (en) * | 2006-10-19 | 2008-04-24 | Auspex Pharmaceuticals, Inc. | Substituted indoles |
| TWI459947B (en) | 2007-06-26 | 2014-11-11 | Otsuka Pharma Co Ltd | Benzazepine compound and pharmaceutical preparation |
| WO2009117144A1 (en) | 2008-03-20 | 2009-09-24 | Concert Pharmaceuticals, Inc. | Benzazepine compounds |
-
2010
- 2010-10-25 US US13/504,101 patent/US8940727B2/en not_active Expired - Fee Related
- 2010-10-25 SG SG10201406839VA patent/SG10201406839VA/en unknown
- 2010-10-25 IN IN3343DEN2012 patent/IN2012DN03343A/en unknown
- 2010-10-25 JP JP2011538404A patent/JP5717645B2/en not_active Expired - Fee Related
- 2010-10-25 EP EP10826651A patent/EP2495236A4/en not_active Withdrawn
- 2010-10-25 KR KR1020127013513A patent/KR20120092139A/en not_active Application Discontinuation
- 2010-10-25 WO PCT/JP2010/068807 patent/WO2011052519A1/en active Application Filing
- 2010-10-25 CN CN201510199726.7A patent/CN104829531A/en active Pending
- 2010-10-25 BR BR112012009784A patent/BR112012009784A2/en not_active IP Right Cessation
- 2010-10-25 AU AU2010312651A patent/AU2010312651A1/en not_active Abandoned
- 2010-10-25 CA CA2778756A patent/CA2778756A1/en not_active Abandoned
- 2010-10-25 EA EA201290228A patent/EA022253B1/en not_active IP Right Cessation
- 2010-10-25 CN CN201080048410.3A patent/CN102753530B/en not_active Expired - Fee Related
- 2010-10-25 CN CN201410616974.2A patent/CN104447555A/en active Pending
- 2010-11-25 MX MX2012004843A patent/MX2012004843A/en unknown
-
2012
- 2012-04-12 ZA ZA2012/02640A patent/ZA201202640B/en unknown
- 2012-04-15 IL IL219132A patent/IL219132A0/en unknown
- 2012-05-24 CO CO12086123A patent/CO6481003A2/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| CN104829531A (en) | 2015-08-12 |
| BR112012009784A2 (en) | 2016-05-17 |
| EA022253B1 (en) | 2015-11-30 |
| US20130131045A1 (en) | 2013-05-23 |
| IL219132A0 (en) | 2012-06-28 |
| IN2012DN03343A (en) | 2015-10-23 |
| EP2495236A4 (en) | 2013-03-27 |
| KR20120092139A (en) | 2012-08-20 |
| US8940727B2 (en) | 2015-01-27 |
| MX2012004843A (en) | 2012-05-29 |
| WO2011052519A1 (en) | 2011-05-05 |
| CO6481003A2 (en) | 2012-07-16 |
| CN102753530B (en) | 2015-06-17 |
| AU2010312651A1 (en) | 2012-05-03 |
| CA2778756A1 (en) | 2011-05-05 |
| EA201290228A1 (en) | 2012-12-28 |
| ZA201202640B (en) | 2013-06-26 |
| JPWO2011052519A1 (en) | 2013-03-21 |
| JP5717645B2 (en) | 2015-05-13 |
| EP2495236A1 (en) | 2012-09-05 |
| CN102753530A (en) | 2012-10-24 |
| CN104447555A (en) | 2015-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY168201A (en) | Agricultural And Horticultural Fungicidal Composition | |
| MX2009010071A (en) | Insecticidal aryl isoxazoline derivatives. | |
| RS54386B1 (en) | Antiviral compounds | |
| MA35452B1 (en) | 3-pyrimidin-4-yl-oxazolidin-2-ones as mutant idh inhibitors | |
| TW200612958A (en) | Substituted imidazole derivatives | |
| MX2012007060A (en) | Nitrogen-containing heterocyclic compound and agricultural/horticultural germicide. | |
| RS54123B1 (en) | Therapeutic combination comprising dolutegravir, abacavir and lamivudine | |
| MX2011008176A (en) | 3, 3' -spiroindolinone derivatives as anticancer agents. | |
| RS54207B1 (en) | Condensed imidazolylimidazoles as antiviral compounds | |
| MX2012009186A (en) | Substituted pyrrolidine-2-carboxamides. | |
| RS53301B (en) | Thioacetate compounds, compositions and methods of use | |
| MY152972A (en) | Azabicyclo compound and salt thereof | |
| MX2010007952A (en) | Insecticidal arylpyrrolines. | |
| WO2008108378A3 (en) | Bicyclic oxomorpholine derivative | |
| MY183312A (en) | Pharmaceutical formulation | |
| RS54730B1 (en) | Inhibitors of beta-secretase | |
| TN2009000287A1 (en) | Cyclized derivatives as eg-5inhibitors | |
| UA108510C2 (en) | Cyclopropane compound | |
| WO2011039735A3 (en) | Compounds with ddx3 inhibitory activity and uses thereof | |
| MX2013000295A (en) | Process of preparing a thrombin specific inhibitor. | |
| TW200800951A (en) | Substituted imidazole compounds as KSP inhibitors | |
| GEP20125637B (en) | Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them | |
| SG10201406839VA (en) | Benzazepine compound | |
| IN2014CN04449A (en) | ||
| MY195881A (en) | Griseofulvin Compound |